2014 Annual Meeting | Cerebrovascular Disease and Interventional Neurology: Clinical and Imaging Biomarkers and Genetics
| 03:15 PM - 05:00 PM | Abstract |
001 - Abnormal Left Ventricular Geometry in Lacunar Stroke: Spectrum, Prevalence and Prognostic Implications in the SPS3 Trial
William Baskett |
| 03:15 PM - 05:00 PM | Abstract |
003 - The Collateral circulation on Day-2 CT Angiography is a reliable predictor of functional outcomes in acute ischemic stroke.
Leonard L. Yeo, MBBS |
| 03:15 PM - 05:00 PM | Abstract |
004 - Identifying Novel Biomarkers of Cerebral Ischemia through the Use of Mass Spectroscopy
Paul M. George, MD, PhD, MSE, FAAN |
| 03:15 PM - 05:00 PM | Abstract |
005 - Proteomic Profiling of Acute Stroke Patients Post IV Thrombolysis: Mapping tPA Efficacy in Real Time
MingMing Ning, MD |
| 03:15 PM - 05:00 PM | Abstract |
006 - COL4A1 Mutations: Clinical and Radiological Phenotypes in a French Adult Cohort
|
| 03:15 PM - 05:00 PM | Abstract |
007 - An autosomal dominant arteriopathy of the brain due to a novel mutation in collagen 4A1 gene in a family with early-onset stroke and leukoencephalopathy
Matthew Schrag, MD |
| Alison Baird, MBBS, PhD, FRACP, MPH | No disclosure on file |
| Glen Jickling, MD | No disclosure on file |
| No disclosure on file | |
| Gordon J. Gubitz, MD | No disclosure on file |
| Robert G. Hart, MD | No disclosure on file |
| Anna M. Szekely, MD | No disclosure on file |
| Stephen J. Phillips, MBBS | No disclosure on file |
| MingMing Ning, MD | No disclosure on file |
| Prakash R. Paliwal, MD | No disclosure on file |
| Leonard L. Yeo, MBBS | The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC. |
| Gregory W. Albers, MD | No disclosure on file |
| Hock Luen Teoh | No disclosure on file |
| Ferdinando Buonanno, MD | No disclosure on file |
| Pierre Labauge, MD | Dr. Labauge has nothing to disclose. |
| Clarisse Carra-Dalliere | No disclosure on file |
| Ahn Hee Seung | No disclosure on file |
| Oscar R. Benavente, MD, FRCP(C) | No disclosure on file |
| Nathan Chan Smyth, MD | No disclosure on file |
| Susan A. Eaton, PharmD | No disclosure on file |
| Wi-Sun Ryu | No disclosure on file |
| Raymond C. Seet, MD | Dr. Seet has nothing to disclose. |
| William D. Graf, MD, FAAN | Dr. Graf has nothing to disclose. |
| Matthew Schrag, MD | No disclosure on file |
| Rohit Bakshi, MD, FAAN | Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. An immediate family member of Dr. Bakshi has received stock or an ownership interest from Biogen. The institution of Dr. Bakshi has received research support from BMS/Celgene. The institution of Dr. Bakshi has received research support from EMD Serono. |
| Michael Mlynash | No disclosure on file |
| Giovanni Castelnovo | No disclosure on file |
| Jean-Marc Olivot | No disclosure on file |
| Tiphaine Rouaud | No disclosure on file |
| Eloi Magnin | No disclosure on file |
| Xavier Ayrignac | Xavier Ayrignac has nothing to disclose. |
| Paul M. George, MD, PhD, MSE, FAAN | Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH. |
| Sonia Alamowitch, MD | No disclosure on file |
| Caroline Arquizan | No disclosure on file |
| Jean Philippe Neau, MD | No disclosure on file |
| William Baskett | No disclosure on file |
| Lawrence I. Golbe, MD | Dr. Golbe has received personal compensation in the range of $0-$499 for serving as a Consultant for Amylyx. Dr. Golbe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aprinoia. Dr. Golbe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ferrer. Dr. Golbe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitochon. Dr. Golbe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IQVIA. Dr. Golbe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Golbe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. Dr. Golbe has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Rossy Centre. Dr. Golbe has received intellectual property interests from a discovery or technology relating to health care. Dr. Golbe has received publishing royalties from a publication relating to health care. Dr. Golbe has a non-compensated relationship as a Chief Clinical Officer, Scientific Advisory Board Chair, Member of the Board of Directors, all as a volunteerd with CurePSP that is relevant to AAN interests or activities. |
| Vijay Sharma | No disclosure on file |
| Teesta B. Soman, MD, MBBS | No disclosure on file |
| Made Wenten | No disclosure on file |
| Claudia Prada | No disclosure on file |